CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vi... - 06 January 2023 17:00

KYOTO, Japan, Jan. 6, 2023 /Kyodo JBN-Asianet/ -- - "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its "Going for Zero" vision to eliminat...

  B dot Medical to Install Its First Practical Ultra-compact Pro... - 05 January 2023 18:00

TOKYO, Jan. 5, 2023 /Kyodo JBN-Asianet/ -- - Memorandum of Understanding Signed with Edogawa Hospital - B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital in Japan for the installation of the company's first practical ultra-compact proton therapy system, w...

  DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Co... - 05 January 2023 11:00

SALT LAKE CITY, Jan. 5, 2023 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3748183-1&h=827169717&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics ), a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies t...

  Alphyn Biologics Reports Positive Results from First Cohort of... - 04 January 2023 23:50

ANNAPOLIS, Md., Jan. 4, 2023 /PRNewswire-Asianet/ -- Study met all primary endpoints Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3747842-1&h=3266796279&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3709054-1%26h%3D2795132862%26u%3Dhttps%253A%252F%2...

  Non-invasive in vitro diagnostic (IVD) test enables early dete... - 27 December 2022 12:21

SAO PAULO, Brazil, Dec. 22, 2022 /Xinhua-AsiaNet/-- The DNA Methylation Detection Kit for Human SDC2, ADHFE1 and PPP2R5C Genes (Real-Time PCR), the colorectal cancer early detection product under BGI's wholly-owned subsidiary BGI Biotechnology (Wuhan) Co., Ltd., has recently obtained the medical de...

  PeproMene Bio, Inc. Announced Complete Response of The First P... - 21 December 2022 12:00

IRVINE, Calif., Dec. 21, 2022 /PRNewswire-AsiaNet/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) cl...

  Huaiyin in Jinan, Shandong, Intent on Transforming into China'... - 20 December 2022 23:04

JINAN, China, Dec. 20, 2022 /Xinhua-AsiaNet/-- According to information released on December 13 by the People's Government of Huaiyin District, Huaiyin will expend all necessary effort on building a new medical science city comprising an international smart medical city, a green health demonst...

  Carrick Therapeutics and The Menarini Group Announce Clinical ... - 20 December 2022 02:24

DUBLIN and FLORENCE, Italy, December 19, 2022 /PRNewswire-AsiaNet/-- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, today announced a ...

  Health and Hydrogen launches one of the first medical-grade Mo... - 19 December 2022 23:28

GURGAON, India, Dec. 19, 2022 /PRNewswire-AsiaNet/ -- Molecular Hydrogen Inhalation therapy is now extensively used for its many health benefits, such as reducing inflammation, improving cellular function, and protecting against oxidative stress. Health And Hydrogen [ https://healthandhydrogen.co...

  CES 2023:OMRON Healthcare Introducing Initiatives to Advance I... - 16 December 2022 19:00

KYOTO, Japan, Dec. 16, 2022 /Kyodo JBN-Asianet/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) will exhibit at CES 2023 (*), the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5, through Sunday, January 8. At the show, the Company will showcase the inn...